Beaumont Hospital
- Address
- Beaumont Road, D09 YD60 Dublin, Ireland
Beaumont Hospital - Infectious Disease & Microbiome Research
Beaumont Hospital is actively engaged in advancing therapeutic interventions for complex infectious diseases, with particular expertise in gastrointestinal infections and microbiome-based therapies. The center participates in cutting-edge clinical research focused on developing novel preventive strategies for recurrent bacterial infections.
- Clostridioides difficile infection prevention and treatment
- Microbiome restoration therapies
- Recurrent gastrointestinal infections
The hospital's research portfolio includes Phase 3 clinical trials investigating live biotherapeutic products designed to prevent recurrent CDI. Through participation in multi-center, placebo-controlled studies, Beaumont Hospital contributes to the development of innovative approaches that address the critical need for preventing disease recurrence in patients who have experienced Clostridioides difficile infection.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Vedanta Biosciences Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Beaumont Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of VE303 for Recurrent Clostridioides difficile Infection Prevention in Adults | Vedanta Biosciences Inc. | Phase III | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live | 1 | Unknown | 2024-10-31 | 2024-10-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.